Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Industry Leader

With extensive experience, Creative Biolabs aims to offer you the best in the field of antibody

De Novo Antibody Sequencing

Antibody Sequencing Service Supports Your Antibody Engineering with All-around Service System.

Global Market

Creative Biolabs serves customers from the USA, Canada, European countries and more

Single Domain Antibody

Single domain antibody—the most promising antibody in disease diagnosis, genetic modification and more

13Jul/20

Cell: Isolated Strong SARS-CoV-2 Neutralizing Antibody from Patients with COVID-19

July 13, 2020Drug Discovery Research, NewsAntibody Discovery, COVID-19biolabs

An important line of defense against novel coronavirus SARS-CoV-2 is the formation of neutralizing antibodies. These antibodies can eliminate invaders and have great potential in the prevention and treatment of SARS-CoV-2 infection.Read More…

02Jun/20

Nature: Major Discovery! A Human Antibody Can Strongly Neutralize A Variety of Coronaviruses, including SARS-CoV and SARS-CoV-2

June 2, 2020Drug Discovery Research, Immunotherapy ResearchAntibody Discovery, COVID-19, SARS-CoV-2biolabs

In a new study, researchers from Humabs Biomed SA and the University of Washington found that an antibody that suppresses the associated coronavirus was identified for the first time in a bloodRead More…

14May/20

Big News! Microbes Control the Health of the Immune System!

May 14, 2020Biological Knowledge, Immunotherapy Research, NewsConventional Dendriticcells, Immune System, immunotherapybiolabs

Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…

26Apr/20

Science: COVID-19 May Relapse Seasonally and the High Temperature in Summer will not Make It Die

April 26, 2020Biological Knowledgebiolabs

Researchers at Harvard University studied the common cold for clues to how the COVID-19 virus might behave. They used close relatives of SARS-CoV-2 to simulate its behavior in the coming months. TheRead More…

17Mar/20

National Institutes of Health (NIH) Has Launched a Clinical Trial of Remdesivir in the Treatment of COVID-19

March 17, 2020NewsCOVID-19, virusbiolabs

Nebraska is conducting the first clinical trial of possible coronavirus treatment, which is expected to eventually include 400 patients in 50 locations around the world, officials said. In this international study, halfRead More…

15Jan/20

Summary of New Drugs with Clinical Trial Progress Approved by FDA in 2019

January 15, 2020Drug Discovery Research, NewsAntibiotics, Diagnostic Reagents, New Drugs, Targeted Drugsbiolabs

Innovation drives progress. Center for Drug Evaluation and Research (CDER) of FDA has been a strong supporter of innovation in the development of new drugs and biotherapy products. By understanding the mechanismRead More…

18Dec/19

Breakthrough! Scientists Have Successfully Reprogrammed T Cells to Improve the Efficacy of Cancer Immunotherapy

December 18, 2019Immunotherapy Researchcell therapy, immunotherapy, T cellbiolabs

In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…

07Nov/19

A New Antibody is Expected to be Developed as a General Influenza Vaccine

November 7, 2019Drug Discovery ResearchAntibody Discovery, Therapeutic Antibody, virusbiolabs

A team of researchers from the United States have found that an antibody that “embeds” influenza virus surface proteins can protect mice from a variety of influenza virus strains and is expectedRead More…

11Oct/19

Comprehensive Analysis of Targeted Drugs for Lung Cancer

October 11, 2019Drug Discovery Research, Immunotherapy Research, Newsimmunotherapy, monoclonal antibody, Small molecule targeted drugsbiolabs

Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…

17Sep/19

Novel Nanotechnology Platform Is Expected to Accelerate the Research in the Field of Stem Cell Transplantation

September 17, 2019Antibody Engineering Research, NewsCell Characterization, Nanotechnology, Stem Cell Transplantationbiolabs

In a study published in the international journal ACS Nano, scientists from Rutgers University have developed a new nanotechnology. It may accelerate the research in the field of stem cell transplantation andRead More…

Posts navigation

  • « Previous
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 17
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Scientists identify a special gene that produces key antibodies in large quantities
  • The molecular mechanism by which special antibodies protect the body against HIV infection
  • Multispecific antibodies enhance cancer immunotherapy
  • Scientists have cracked HIV’s new way of entering the host cell nucleus, which may lead to new therapeutic drugs
  • Antibody sequencing provides a new path for antibody therapy research

Archives

Contact Us

USA – UK

Copyright © Creative Biolabs Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research